Last reviewed · How we verify

NCT05591885

Nutrilite Memory Builder on the Improvement of Cognitive Function

Status unknown NA Last updated 28 April 2023
What this trial tests

NA trial testing Study product group (Nutrilite Memory Builder) in Cognitive Function in 100 participants. Status unknown.

Timeline
24 October 2022
Primary endpoint
31 May 2023
31 May 2023

Quick facts

Lead sponsorAmway (China) R&D Center
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment100
Start date24 October 2022
Primary completion31 May 2023
Estimated completion31 May 2023
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Amway (China) R&D Center

Who can join

Adults 40 to 75, any sex, with Cognitive Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Its a randomized controlled trial, to evaluate the effect of NUTRILITE Memory Builder on the improvement of cognitive function in middle-aged and elderly people.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cognitive Function

Currently open trials in the same condition.

Other Amway (China) R&D Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05591885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing